Clinical Trial Update: Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib in Treating Anemic MPN Patients [Phase 2]

View source ↗

Summary

Phase 2 intra-patient dose-escalation trial assessing the safety and feasibility of Vactosertib in anemic myeloproliferative neoplasm patients; the study was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloproliferative Neoplasm

Drugs mentioned

• Vactosertib (Vactosertib)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Myeloproliferative Neoplasm | Phase 2 | Status: TERMINATED | Results posted: 2025-07-02